US Stock MarketDetailed Quotes

BioCryst Pharmaceuticals (BCRX)

Watchlist
  • 7.170
  • +0.390+5.75%
Close Jan 15 15:59 ET
  • 7.160
  • -0.010-0.14%
Post 20:01 ET
1.51BMarket Cap-143.40P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioCryst Pharmaceuticals (BCRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
36.14%159.4M
49.41%163.35M
56.89%145.53M
36.00%450.71M
40.83%131.53M
34.98%117.09M
32.54%109.33M
34.87%92.76M
22.37%331.41M
17.42%93.4M
Operating revenue
36.14%159.4M
49.41%163.35M
56.89%145.53M
36.00%450.71M
36.58%131.53M
36.65%117.09M
32.54%109.33M
34.87%92.76M
22.37%331.41M
21.07%96.31M
Cost of revenue
-31.89%2.19M
64.69%2.8M
261.11%4.57M
167.86%12.49M
285.46%6.31M
182.66%3.21M
78.84%1.7M
34.86%1.27M
-29.31%4.66M
-34.42%1.64M
Gross profit
38.05%157.21M
49.17%160.56M
54.07%140.97M
34.12%438.23M
36.46%125.22M
33.02%113.87M
32.00%107.63M
34.87%91.5M
23.66%326.75M
19.10%91.76M
Operating expense
20.19%127.62M
32.26%130.77M
12.98%119.74M
2.40%440.77M
-3.50%129.73M
8.87%106.18M
-3.30%98.87M
10.11%105.98M
4.31%430.46M
8.98%134.43M
Selling and administrative expenses
27.52%83.01M
42.67%87.38M
38.62%82.47M
24.42%266.13M
24.71%80.29M
28.54%65.1M
20.10%61.25M
24.28%59.49M
34.21%213.89M
28.37%64.38M
Research and development costs
8.57%44.6M
15.32%43.39M
-19.84%37.27M
-19.36%174.64M
-29.42%49.44M
-12.37%41.08M
-26.58%37.62M
-3.92%46.49M
-14.50%216.57M
-4.31%70.05M
Operating profit
284.70%29.59M
239.98%29.79M
246.51%21.23M
97.55%-2.54M
89.44%-4.51M
164.52%7.69M
142.32%8.76M
49.01%-14.49M
30.13%-103.71M
7.86%-42.67M
Net non-operating interest income expense
17.96%-17.42M
9.98%-19.07M
0.02%-20.47M
9.40%-83.77M
-3.78%-20.88M
8.31%-21.24M
15.84%-21.18M
14.75%-20.48M
1.60%-92.46M
15.31%-20.12M
Non-operating interest income
-37.68%2.24M
-29.21%2.52M
-24.98%3.02M
-6.53%14.75M
-20.04%3.57M
-14.17%3.59M
-5.23%3.55M
19.33%4.03M
207.72%15.78M
65.13%4.47M
Non-operating interest expense
-20.81%19.66M
-12.74%21.58M
-4.13%23.49M
-8.98%98.52M
-0.55%24.45M
-9.20%24.83M
-14.46%24.73M
-10.55%24.51M
9.23%108.24M
-7.09%24.58M
Other net income (expense)
-138.78%-38K
-4,940.48%-4.23M
101.96%1K
97.87%-641K
-61.50%-604K
113.30%98K
99.71%-84K
77.73%-51K
-1,415.78%-30.06M
73.29%-374K
Gain on sale of security
-64.29%35K
25.00%-63K
101.96%1K
38.31%-641K
-61.50%-604K
113.30%98K
-127.91%-84K
77.73%-51K
47.60%-1.04M
73.29%-374K
Special income (charges)
---2.74M
---4.17M
----
--0
--0
--0
--0
----
---29.02M
--0
-Less:Other special charges
--2.74M
--4.17M
----
----
----
----
----
----
--29.02M
--0
Other non- operating income (expenses)
--2.67M
----
----
----
----
----
----
----
----
----
Income before tax
190.21%12.13M
151.88%6.49M
102.16%758K
61.56%-86.95M
58.85%-25.99M
62.46%-13.45M
83.24%-12.5M
33.51%-35.01M
7.43%-226.23M
11.62%-63.16M
Income tax
-231.23%-769K
714.53%1.4M
98.90%726K
521.61%1.93M
156.18%804K
77.58%586K
-76.76%172K
-45.60%365K
-88.66%310K
-1,982.89%-1.43M
Net income
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
Net income continuous Operations
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
Minority interest income
Net income attributable to the parent company
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
Basic earnings per share
185.71%0.06
133.33%0.02
0
63.56%-0.43
58.06%-0.13
63.16%-0.07
85.00%-0.06
39.29%-0.17
11.28%-1.18
18.42%-0.31
Diluted earnings per share
185.71%0.06
133.33%0.02
0
63.56%-0.43
58.06%-0.13
63.16%-0.07
85.00%-0.06
39.29%-0.17
11.28%-1.18
18.42%-0.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 36.14%159.4M49.41%163.35M56.89%145.53M36.00%450.71M40.83%131.53M34.98%117.09M32.54%109.33M34.87%92.76M22.37%331.41M17.42%93.4M
Operating revenue 36.14%159.4M49.41%163.35M56.89%145.53M36.00%450.71M36.58%131.53M36.65%117.09M32.54%109.33M34.87%92.76M22.37%331.41M21.07%96.31M
Cost of revenue -31.89%2.19M64.69%2.8M261.11%4.57M167.86%12.49M285.46%6.31M182.66%3.21M78.84%1.7M34.86%1.27M-29.31%4.66M-34.42%1.64M
Gross profit 38.05%157.21M49.17%160.56M54.07%140.97M34.12%438.23M36.46%125.22M33.02%113.87M32.00%107.63M34.87%91.5M23.66%326.75M19.10%91.76M
Operating expense 20.19%127.62M32.26%130.77M12.98%119.74M2.40%440.77M-3.50%129.73M8.87%106.18M-3.30%98.87M10.11%105.98M4.31%430.46M8.98%134.43M
Selling and administrative expenses 27.52%83.01M42.67%87.38M38.62%82.47M24.42%266.13M24.71%80.29M28.54%65.1M20.10%61.25M24.28%59.49M34.21%213.89M28.37%64.38M
Research and development costs 8.57%44.6M15.32%43.39M-19.84%37.27M-19.36%174.64M-29.42%49.44M-12.37%41.08M-26.58%37.62M-3.92%46.49M-14.50%216.57M-4.31%70.05M
Operating profit 284.70%29.59M239.98%29.79M246.51%21.23M97.55%-2.54M89.44%-4.51M164.52%7.69M142.32%8.76M49.01%-14.49M30.13%-103.71M7.86%-42.67M
Net non-operating interest income expense 17.96%-17.42M9.98%-19.07M0.02%-20.47M9.40%-83.77M-3.78%-20.88M8.31%-21.24M15.84%-21.18M14.75%-20.48M1.60%-92.46M15.31%-20.12M
Non-operating interest income -37.68%2.24M-29.21%2.52M-24.98%3.02M-6.53%14.75M-20.04%3.57M-14.17%3.59M-5.23%3.55M19.33%4.03M207.72%15.78M65.13%4.47M
Non-operating interest expense -20.81%19.66M-12.74%21.58M-4.13%23.49M-8.98%98.52M-0.55%24.45M-9.20%24.83M-14.46%24.73M-10.55%24.51M9.23%108.24M-7.09%24.58M
Other net income (expense) -138.78%-38K-4,940.48%-4.23M101.96%1K97.87%-641K-61.50%-604K113.30%98K99.71%-84K77.73%-51K-1,415.78%-30.06M73.29%-374K
Gain on sale of security -64.29%35K25.00%-63K101.96%1K38.31%-641K-61.50%-604K113.30%98K-127.91%-84K77.73%-51K47.60%-1.04M73.29%-374K
Special income (charges) ---2.74M---4.17M------0--0--0--0-------29.02M--0
-Less:Other special charges --2.74M--4.17M--------------------------29.02M--0
Other non- operating income (expenses) --2.67M------------------------------------
Income before tax 190.21%12.13M151.88%6.49M102.16%758K61.56%-86.95M58.85%-25.99M62.46%-13.45M83.24%-12.5M33.51%-35.01M7.43%-226.23M11.62%-63.16M
Income tax -231.23%-769K714.53%1.4M98.90%726K521.61%1.93M156.18%804K77.58%586K-76.76%172K-45.60%365K-88.66%310K-1,982.89%-1.43M
Net income 191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M
Net income continuous Operations 191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M
Minority interest income
Net income attributable to the parent company 191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M
Basic earnings per share 185.71%0.06133.33%0.02063.56%-0.4358.06%-0.1363.16%-0.0785.00%-0.0639.29%-0.1711.28%-1.1818.42%-0.31
Diluted earnings per share 185.71%0.06133.33%0.02063.56%-0.4358.06%-0.1363.16%-0.0785.00%-0.0639.29%-0.1711.28%-1.1818.42%-0.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -